Dr. Nattel undertook MD, Internal Medicine and Clinical Pharmacology training at McGill, then cardiology and research training at Indiana University and University of Pennsylvania. He returned to McGill in 1981 and in 1987 transferred to the Montreal Heart Institute, where he directed the Research Center between 1990 and 2004. He is presently Paul-David Chair in Cardiovascular Electrophysiology and Director of the Electrophysiology Research Program. He is Editor in Chief of the Canadian Journal of Cardiology, Associate Editor of Cardiovascular Research, Rhythm Disorders Section Editor in JACC, and is on many other editorial boards. His h-index is 155; he has over 130,000 citations. His research focuses on clinically-relevant mechanisms of cardiac bioelectricity.

Dr. Maurice Enriquez-Sarano is a cardiologist with expertise in heart valve diseases and cardiac imaging. He got his MD degree and medical training from Sorbonne University, Paris, France.  He joined the Mayo Clinic, was the founding director of the Heart Valve Clinic and Professor of Medicine at Mayo Clinic, Rochester, MN, and was a founding member and past-president of the Heart Valve Society. Dr. Sarano authored over 500 peer-reviewed publications and book chapters, with h-index 108 (Scopus) to 118 (Google) and mentored numerous trainees who became leading scholars in valve diseases. He is Senior Scientist at the Minneapolis Heart Institute and founder of ValThera (ValThera.io), a startup developing innovative transcatheter treatment for tricuspid regurgitation.  He is a member of “La Chaine de L’espoir” and board member of “United Surgeons for Children”, supporting the treatment of patients affected by Valvular Heart Diseases in low-resources countries.

Dr. Lincoff is Vice Chair for Research and an interventional cardiologist in the Department of Cardiovascular Medicine at the Cleveland Clinic.  He is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and holds the Charles and Charlotte Fowler Endowed Chair for Cardiovascular Research.  His research activities focus on development of metabolic or antithrombotic therapies to prevent or reduce progression of atherosclerosis or optimize management of acute coronary syndromes or percutaneous coronary intervention.  He has served as principal investigator or steering committee member for over 50 trials in ischemic and cardiometabolic diseases.

Debbie A. Rinde-Hoffman, M.D., F.A.C.C., is the TGH Heart & Vascular Institute Vice-Chief of Business Development and Physician Network. For decades, she led the TGH Heart Transplant Program, establishing the LVAD program, Heart Failure Center of Excellence, co-establishing Florida’s first comprehensive Cardiogenic Shock Program, and establishing the reputation of TGH’s Advanced Heart Failure Program as one of the world’s best. Dr. Hoffman completed her medical training, including medical school, internal medicine internship, residency, and fellowship in cardiology at the University of South Florida in Tampa, Florida, with special training and proficiency in nuclear cardiology, cardiac transplantation, echocardiography, diagnostic cardiac catheterization, percutaneous transluminal angioplasty, excimer laser angioplasty, and intracoronary stent placement. She is a Fellow of the American College of Cardiology and is board certified in internal medicine, cardiovascular disease, advanced heart failure and heart transplant by the American Board of Internal Medicine. In addition, she served as chief of the Department of Internal Medicine at Tampa General Hospital and as the medical director of the cardiac transplantation and mechanical circulatory support teams. She is also an affiliate associate professor at the USF Health Morsani College of Medicine. Dr. Rinde-Hoffman has had numerous articles published in the area of cardiac transplantation. She is a sought-after speaker on issues related to women with heart disease, congestive heart failure, transplantation, and mechanical assist devices. She is a member of numerous professional and scientific societies including the American Medical Association, American College of Physicians, and Florida Medical Association.

Amir Lerman, MD. Is an endowed named Barbara Lips professor of medicine and a consultant in the department of cardiovascular disease at the Mayo graduate school of medicine. Dr. Lerman serves as an associate chair of the department of Cardiology and the Director of the cardiovascular research center at Mayo Clinic and the medical director of the chest pain and coronary physiology clinic. Dr. Lerman serves as the Director Mayo-Israeli start-up companies initiative and on the faculty member of the Merage Institute for medical innovation.  Dr. Lerman graduated from the Technion school of Medicine in Haifa Israel and completed his training in internal medicine, cardiovascular diseases and invasive cardiology at the Mayo Clinic. Dr. Leman interest is coronary physiology and imaging, regenerative medicine, innovative technologies and digital health. Dr. Lerman published more than 650 manuscripts, book chapters and reviews; the NIH, AHA, and several foundations support his research.